Australia turns down appeal to reclassify nicotine for e-cigarette use
Australian authorities have refused to legalise nicotine-containing e-liquid despite appeals to support e-cigarettes for harm reduction.
BAT / RAI Strike A Deal--Stronger Together
BAT/RAI Reach Definitive Agreement - Offer Revised to $59.64/Share (Parity) As We Expected – BAT/RAI Deal Likely Increases the Probability of a PM/MO Combo
Designating CBD as a medicine will impede it’s potential for virtuous development in the industry
Allowing CBD to come under the rule of Pharma would be calamitous for the industry and allow for price gouging, tight regulation, and other such destructive practices
World Health Organization plays dirty and kicks media & trade groups out
World Health Organization rallies against E-Cigarettes and refuses to allow ANY media or trade groups into tobacco control conference in India while welcoming Big Pharma and others with conflicts of interest. What are they hiding?
European Parliament Questions The European Commission on iQOS by Philip Morris
Phillip Morris's new brand of "Heat, not Burn" Tobacco products have come under heavy scrutiny in the EU Parliament in recent days due to some serious health concerns
"Heat, Not Burn" is NO E-Cigarette
"Heat, Not Burn" has recently made it's appearance being marketed as an E-Cigarette. There are, However, a few very important differences that separate the two in a substantial way.
Phillip Morris staying with it's traditional tobacco roots with "heat not burn" while BAT bets on next-gen vapor technology
BAT Puts it's efforts into it's new vapor product which boasts faster nicotine delivery & a better consumer sensation whilst Phillip Morris sticks close by it's traditional tobacco roots with iqos. Will "old tobacco" rise above or simply go up in vapor?
Contrary to the DEA’s Revised Ruling, CBD is NOT Illegal.
If the future of hemp-derrived CBD is looking bleak, take heart. In simple terms, the revised ruling by the DEA as published in this week’s Federal Registry is misleading and irrelevant. CBD is NOT illegal.

Tobacco Vapor Electronic Cigarette Association

TVECA is an international nonprofit trade association. Our organization is dedicated to creating a sensible and responsible electronic cigarette market by providing the media, legislative bodies and consumers with education, communication and research.

Call: 1 (888) 99-TVECA

Fax: 1 (888) 332-2058

Email: info@tveca.com

President Donald Trump has nominated Dr. Scott Gottlieb to be the next Commissioner of the FDA

U.S. President Donald Trump has chosen Dr. Scott Gottlieb, a conservative health policy expert with deep ties to the pharmaceutical industry, to lead the U.S. Food and Drug Administration, the White House said on Friday.

If confirmed by the Senate, Gottlieb would be in charge of implementing Trump's plan to dramatically cut regulations governing food, drugs, cosmetics, dietary supplements and tobacco.

Gottlieb is well known on Capitol Hill, where he has testified multiple times on hot-button health issues, including complex drug pricing matters, and is viewed favorably by drug companies and pharmaceutical investors. He sits on the boards of several small drug and biotech companies and is an adviser to GlaxoSmithKline Plc (GSK.L).

"Thank God it's Gottlieb," Brian Skorney, an investment analyst at Robert W. Baird, wrote in a research note. "We view this as a favorable development for the sector."

Gottlieb was chosen over Jim O'Neill, a libertarian investor close to Silicon Valley billionaire Peter Thiel, a PayPal co-founder who now advises Trump on technology and science matters. O'Neill's stated view that drugs should be approved before being proven effective generated widespread alarm.

Gottlieb, 44, is a resident fellow at the conservative American Enterprise Institute think tank and a partner at a large venture capital fund. He is a former FDA deputy commissioner who has advocated a loosening of requirements needed for approval of new medical products.

"Scott knows how the agency works and he will move it forwards, though maybe not always in ways the agency is comfortable with," said John Taylor, a lawyer and president of compliance and regulatory affairs with the consulting firm Greenleaf Health and a former acting FDA deputy commissioner.

In addition to his public health and health policy roles, Gottlieb has for the past decade been a partner at New Enterprise Associates, a large venture fund with investments in the life sciences, medical technology and healthcare services.

Critics of the nomination say Gottlieb's financial background present an array of potential conflicts of interest.

Dr. Michael Carome, director of Public Citizen's Health Research Group, said Gottlieb "has spent most of his career dedicated to promoting the financial interests of the pharmaceutical industry." If confirmed, he added, "he will have to be recused from key decisions time and time again."

You can read more Here

TVECA Members

TVECA
Go to top